Loss of Expression for the WNT Pathway Components Adenomatous Polyposis Coli and Glycogen Synthase Kinase 3-Β in Parathyroid Carcinomas

International Journal of Oncology - Greece
doi 10.3892/ijo_00000173
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Spandidos Publications

Related search

Activating the WNT/Β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3

PLoS ONE
Multidisciplinary
2015English

Glycogen Synthase Kinase-3

International Journal of Alzheimer's Disease
AgingCognitive NeuroscienceMolecular NeuroscienceNeurologyBehavioral NeuroscienceCellular
2011English

Adenomatous Polyposis Coli (APC) Regulates miR17-92 Cluster Through Β-Catenin Pathway in Colorectal Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2016English

Glycogen Synthase Kinase-3 in Insulin and WNT Signalling: A Double-Edged Sword?

Biochemical Society Transactions
Biochemistry
2004English

Cilia, Adenomatous Polyposis Coli and Associated Diseases

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: Inhibitors of the WNT/Β-Catenin Signaling Pathway as Novel Anticancer Drugs

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2009English

Glycogen Synthase Kinase 3-Β Inhibition Induces Lymphangiogenesis Through Β-Catenin-Dependent and mTOR-independent Pathways

PLoS ONE
Multidisciplinary
2019English

Immunopurification of Adenomatous Polyposis Coli (APC) Proteins

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2013English

Adenomatous Polyposis Coli in an Elderly Female Nigerian

Ghana Medical Journal
Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy